Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% |
|
-11.11% | +9.09% |
08:05am | PYC Therapeutics Advances Trial for Drug Candidate; Shares Up 4% | MT |
18/06 | Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 37Cr | |
+18.15% | 4.55TCr | |
-9.05% | 3.85TCr | |
+38.08% | 3.81TCr | |
+26.36% | 3.07TCr | |
-8.64% | 2.6TCr | |
+11.73% | 2.59TCr | |
+46.58% | 1.41TCr | |
+33.72% | 1.27TCr | |
-7.13% | 1.13TCr |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- Transcript : PYC Therapeutics Limited, Q2 2022 Earnings Call, May 31, 2022